HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali H Hajeer Selected Research

Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)

7/2002Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura.
5/2002Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis exhibit different HLA-DRB1 associations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ali H Hajeer Research Topics

Disease

6Rheumatoid Arthritis
06/2003 - 02/2002
4Critical Illness (Critically Ill)
11/2021 - 01/2015
4Infections
01/2021 - 01/2015
4Purpura
11/2002 - 05/2002
2Coronavirus Infections
11/2021 - 01/2021
2Breast Neoplasms (Breast Cancer)
08/2010 - 02/2008
2Nephritis
11/2002 - 05/2002
2Cutaneous Leukocytoclastic Vasculitis (Hypersensitivity Angiitis)
07/2002 - 05/2002
1Cytokine Release Syndrome
01/2021
1Virus Diseases (Viral Diseases)
01/2015
1Necrosis
12/2014
1Delayed Graft Function
12/2014
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2013
1Hemorrhage
12/2010
1Shock
12/2010
1Septic Shock (Toxic Shock Syndrome)
12/2010
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
12/2010
1Fibrosis (Cirrhosis)
12/2010
1Neoplasms (Cancer)
08/2010
1Prostatic Neoplasms (Prostate Cancer)
08/2010
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2004
1Vascular Skin Diseases
11/2002
1Erythema Nodosum
08/2002
1Sarcoidosis (Schaumann Disease)
08/2002
1Renal Insufficiency (Renal Failure)
07/2002
1Nephrotic Syndrome (Syndrome, Nephrotic)
07/2002
1Vasculitis (Vasculitides)
05/2002
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
03/2002

Drug/Important Bio-Agent (IBA)

6HLA-DRB1 Chains (HLA DRB1)IBA
05/2013 - 02/2002
4EpitopesIBA
06/2003 - 02/2002
2Interleukin-8 (Interleukin 8)IBA
01/2021 - 11/2002
2HLA Antigens (Human Leukocyte Antigens)IBA
07/2016 - 06/2002
2Anti-Bacterial Agents (Antibiotics)IBA
08/2010 - 02/2008
1RNA (Ribonucleic Acid)IBA
11/2021
1Immunoglobulin G (IgG)IBA
11/2021
1CytokinesIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
01/2021
1Interleukin-3 (Interleukin 3)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
12/2014
1Adrenocorticotropic Hormone (ACTH)FDA Link
12/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2010
1Pharmaceutical PreparationsIBA
02/2008
1Fc Receptors (Fc Receptor)IBA
10/2004
1IgG Receptors (Fc gamma RI)IBA
10/2004
1HLA-DRB1*04 antigenIBA
06/2003
1Corticotropin-Releasing HormoneIBA
05/2003
1Peptides (Polypeptides)IBA
11/2002
1Chemokine CCL5IBA
11/2002
1Macrophage Migration-Inhibitory FactorsIBA
08/2002
1Rheumatoid FactorIBA
08/2002
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
07/2002
1HLA-B Antigens (HLA-B)IBA
05/2002
1HLA-B35 Antigen (HLA B35 Antigen)IBA
05/2002
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2002
1Cyclosporine (Ciclosporin)FDA LinkGeneric
02/2002

Therapy/Procedure

1Enteral Nutrition (Feeding, Tube)
12/2018
1Caloric Restriction
12/2018
1Immunotherapy
01/2016
1Therapeutics
01/2015
1Renal Dialysis (Hemodialysis)
12/2014
1Plasmapheresis
12/2014